The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Global Bioenergies Management
Management criteria checks 4/4
Global Bioenergies' CEO is Marc Delcourt, appointed in Feb 2009, has a tenure of 16.83 years. total yearly compensation is €175.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.68% of the company’s shares, worth €9.00K. The average tenure of the management team and the board of directors is 7.2 years and 5.5 years respectively.
How has Marc Delcourt's remuneration changed compared to Global Bioenergies's earnings?
Date
Total Compensation
Salary
Company Earnings
Dec 31 2024
€175k
€175k
-€6m
Sep 30 2024
n/a
n/a
-€7m
Jun 30 2024
n/a
n/a
-€7m
Mar 31 2024
n/a
n/a
-€8m
Dec 31 2023
€351k
€145k
-€9m
Sep 30 2023
n/a
n/a
-€9m
Jun 30 2023
n/a
n/a
-€10m
Mar 31 2023
n/a
n/a
-€11m
Dec 31 2022
€223k
€145k
-€12m
Sep 30 2022
n/a
n/a
-€11m
Jun 30 2022
n/a
n/a
-€10m
Mar 31 2022
n/a
n/a
-€11m
Dec 31 2021
€288k
€135k
-€12m
Sep 30 2021
n/a
n/a
-€12m
Jun 30 2021
n/a
n/a
-€12m
Mar 31 2021
n/a
n/a
-€11m
Dec 31 2020
€242k
€125k
-€11m
Sep 30 2020
n/a
n/a
-€13m
Jun 30 2020
n/a
n/a
-€12m
Mar 31 2020
n/a
n/a
-€12m
Dec 31 2019
€194k
€125k
-€14m
Sep 30 2019
n/a
n/a
-€13m
Jun 30 2019
n/a
n/a
-€12m
Mar 31 2019
n/a
n/a
-€13m
Dec 31 2018
€155k
€155k
-€14m
Compensation vs Market: Marc's total compensation ($USD204.01K) is below average for companies of similar size in the French market ($USD341.41K).
Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.
CEO
Marc Delcourt (53 yo)
16.8yrs
Tenure
€175,000
Compensation
Mr. Marc Delcourt is a Co-Founder of Global Bioenergies and serves as its Chief Executive Officer since February 13, 2009. Mr. Delcourt was the Founder of Biomethodes SA and served as its Chairman, Preside...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Marc Delcourt
Co-Founder
16.8yrs
€175.00k
2.68% € 9.0k
Philippe Marliere
Co-Founder & President of Scientific Advisory Board
no data
no data
no data
Samuel Dubruque
Administrative & Financial Director and CFO
8.2yrs
no data
no data
Frédéric Ollivier
Technical Director
6.3yrs
no data
no data
Claudia Erning
Vice President of Investor Relations
11.9yrs
no data
no data
Alexandra Moncada
Legal Director
5.3yrs
no data
no data
Martin Stephan
Chief Business Officer
2.2yrs
no data
no data
7.2yrs
Average Tenure
Experienced Management: ALGBE's management team is seasoned and experienced (7.2 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Marc Delcourt
Co-Founder
16.8yrs
€175.00k
2.68% € 9.0k
Philippe Marliere
Co-Founder & President of Scientific Advisory Board
no data
no data
no data
Pierre Levi
Independent Director
6.7yrs
€16.20k
no data
Donald Hilvert
Member of Scientific Advisory Board
no data
no data
no data
Pierre Monsan
Independent Director
4.3yrs
€17.40k
no data
Dieter Soll
Member of Scientific Advisory Board
no data
no data
no data
Jean-Marc Paris
Member of Scientific Advisory Board
no data
no data
no data
Bernard Badet
Member of Scientific Advisory Board
no data
no data
no data
Jean Weissenbach
Member of Scientific Advisory Board
no data
no data
no data
Yves Gimbert
Member of Scientific Advisory Board
no data
no data
no data
Terence Hwa
Member of Scientific Advisory Board
no data
no data
no data
Marie-Odile Lavenant
Independent Director
3.5yrs
€15.45k
no data
5.5yrs
Average Tenure
68yo
Average Age
Experienced Board: ALGBE's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/12/04 21:17
End of Day Share Price
2025/12/04 00:00
Earnings
2024/12/31
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Global Bioenergies SA is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.